| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2289971d14c8a733c4987ab6a1325c8d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08 |
| filingDate |
2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b9f47f492a5e00b6c1b3615d7ad1b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b916e06f4747c0f07de2faa5dd9c6a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34be64df49be7119eea38e7e29a6f3ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f220da88a45acda2f1524adc843fa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f28309901975f179f91244bd26f985f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49b6e7e85ae8553083429b4125f20711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963941452cd9d71d42035985fe15f400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b23b2a1d340cc87f57110dcd20aaa2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b76a143f873c91695c8eeba516893ba9 |
| publicationDate |
2017-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2630304-C2 |
| titleOfInvention |
Monoclonal antibody, binding with ebola virus glycoprotein, dna fragments coding this antibody, and antigen-binding fragment |
| abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to a monoclonal antibody selectively binding the Ebola virus glycoprotein with a dissociation constant of complex 2.6∙10 -9 ⋅M, as well as to an isolated DNA fragment encoding the light and heavy chain regions of the said antibody, and an antigen-binding fragment of the said monoclonal antibody. The specificity of the monoclonal antibody to the Ebola virus glycoprotein was confirmed by immunoassay and immunoblotting. The amino acid and nucleotide sequences of the variable domains of the monoclonal antibody are determined. n EFFECT: invention allows preparation of new monoclonal antibodies selectively binding the Ebola virus glycoprotein. n 4 cl, 4 dwg, 2 tbl, 3 ex |
| priorityDate |
2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |